Proposed Data Collections Submitted for Public Comment and Recommendations, 66976-66977 [E9-30014]
Download as PDF
<![CDATA[
66976
Federal Register / Vol. 74, No. 241 / Thursday, December 17, 2009 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
...........................................................
........................
........................
........................
Form
Total ...........................................
Dated: December 10, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–30015 Filed 12–16–09; 8:45 am]
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
BILLING CODE 4163–18–P
Proposed Project
Centers for Disease Control and
Prevention
[60Day-10–0761]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
11,447
not found evidence for the effectiveness
of screening to improve outcomes for
women exposed to IPV.
Based on the recommendations of an
expert panel convened, CDC is
proposing to conduct a randomized
controlled trial to provide this evidence.
The trial will recruit 2675 women in a
network of women’s health clinics.
Women attending these clinics tend to
be African American and of lower
socioeconomic status. For this study,
women will be randomly allocated to
one of three arms: (1) Screened for IPV,
and if disclosing IPV, provided
information on available IPV services;
(2) not screened and all receiving
information on available IPV services; or
(3) a control group that will not be
screened nor receive information on
available IPV services. All three arms
will be assessed with a self-report
measure for disability, quality of life,
and utilization of health services at
baseline utilizing an audio-computerassisted structured interview (A–CASI)
and at a 12-month follow-up utilizing a
computerized-assisted telephone
interview (CATI). The results from this
Randomized Controlled Trial, will guide
CDC as well as other governmental
agencies, professional and health care
organizations, and women’s advocate
groups in formulating its
recommendations and policies
regarding routine screening. A pretest
with 196 women in a women’s health
clinic was conducted to test the
enrollment, randomization, interview,
and follow-up procedures; and provide
estimates for outcome measures. Based
on the results of the pretest, CDC has
revised the measures, procedures, and
sample size requirements for the
Randomized Controlled Trial. There are
no costs to respondents other than their
time to participate in the survey.
Randomized Controlled Trial of
Routine Screening for Intimate Partner
Violence (OMB No. 0920–0761 Exp. 1/
31/2011)—Revision—National Center
for Injury Prevention and Control
(NCIPC), Centers for Disease Control
and Prevention (CDC).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Total burden
hours
Background and Brief Description
Intimate partner violence (IPV) is a
prevalent problem with serious health
consequences that include death,
physical injury, increased rates of
physical illness, posttraumatic stress,
increased psychological distress,
depression, substance abuse, and
suicide. Some studies suggest that abuse
perpetrated by intimate partners tends
to be repetitive and escalates in severity
over time. This research has been the
basis for promoting early diagnosis and
intervention.
Health care providers appear to be
well situated to identify IPV. Women
come into contact with health care
services routinely for a number of
reasons such as prenatal care, family
planning, cancer screening, and well
baby care. Women experiencing IPV
make more visits to emergency
departments, primary care facilities, and
mental health agencies than non-abused
women. Considering the magnitude and
severity of IPV, and the potential role
health care providers could play in
reducing its serious consequences,
numerous professional and health care
organizations have recommended
routine screening of women for IPV in
primary care settings. However, various
systematic reviews of the literature have
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden
response
(in hours)
Annual burden
(in hours)
Type of respondents
Form name
Women Seeking Health Care Services.
Eligibility Script for Pretest ...............
70
1
1/60
2
Baseline Questionnaire Pretest .......
Follow-up Questionnaire Pretest ......
65
59
1
1
15/60
12/60
17
12
VerDate Nov<24>2008
13:19 Dec 16, 2009
Jkt 220001
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
E:\FR\FM\17DEN1.SGM
17DEN1
66977
Federal Register / Vol. 74, No. 241 / Thursday, December 17, 2009 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
Number of
responses per
respondent
Number of
respondents
Form name
Average
burden
response
(in hours)
Annual burden
(in hours)
Eligibility Script for Main Study ........
Baseline Questionnaire Main Study
Follow-up Questionnaire Main Study
(estimated 30% lost to follow-up).
Total ...........................................
668
535
356
1
1
1
1/60
16/60
21/60
12
143
125
...........................................................
........................
........................
........................
311
Dated: December 11, 2009.
Marilyn S. Radke,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. E9–30014 Filed 12–16–09; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
[60Day-10–0735]
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
13:19 Dec 16, 2009
Jkt 220001
CDC Web site and Communication
Channels Usability Evaluation (OMB
No. 0925–0735, Exp. 3/31/2010)—
Revision—National Center for Health
Marketing (NCHM), Centers for Disease
Control and Prevention (CDC.)
Background and Brief Description
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Nov<24>2008
Proposed Project
Executive Order 12862 directs Federal
agencies that provide significant
services directly to the public to survey
customers to determine the kind and
quality of services they need and their
level of satisfaction with existing
services. The Centers for Disease
Control and Prevention (CDC) seeks
approval to conduct usability surveys
on CDC Web sites, social media, mobilebased or other electronic
communication channels hosting CDC
content on an ongoing basis.
It is important for CDC to ensure that
health information, interventions, and
programs at CDC are based on sound
science, objectivity, and continuous
customer input. The CDC Web sites,
social media, mobile-based or other
electronic communication channels
hosting CDC content must be designed
to be easy to use, easy to access, and
effective providers of health information
and resources to our target audiences.
CDC is requesting renewal of our
existing 3-year generic clearance, with
revisions, in order to carry out its
mission. This revised proposal requests
clearance for usability surveys on the
Centers for Disease Control and
Prevention (CDC) Web site and, in
addition, social media, mobile-based or
other electronic communication
channels hosting CDC content. With the
previous Usability Evaluation package,
various groups around the agency were
able to conduct useful surveys assessing
the usability of a variety of CDC Web
sites. These surveys covered important
CDC programs and topics, such as
Seasonal Flu, Tuberculosis, HIV, STDs,
and Chronic Diseases. The CDC.gov
Homepage and other CDC Web sites
were redesigned based on usability
surveys conducted within this package
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
and the resulting designs improved
performance for Web site users and won
numerous awards, both within and
outside of, the Federal government
space. The next step is to continue
usability surveys on more Web sites,
staying abreast of changes in target
audience needs and online behavior as
well as survey users of CDC social
media, mobile-based or other electronic
communication channels hosting CDC
content that currently exist or will
emerge during the life of this package.
CDC is currently using mobile Web
sites, text messaging, online quizzes,
widgets, podcasts, eCards, online video,
motion graphics, blogs, syndicated
content, and other communication
channels and will continue to explore
other channels which provide CDC
content to target audiences when,
where, and how they want and need it.
As new channels emerge, CDC will
explore using them to deliver its
content.
Usability surveys determine how well
CDC’s Web site, social media, mobilebased or other electronic
communication channels hosting CDC
content are performing. Observation and
data collection on how users interact
with the Web site or other electronic
communication channels hosting CDC
content are critical in ensuring that
users can find information, that the Web
site or other electronic communication
channels are easy to use and designed
to meet the needs of specific audiences.
This package requests clearance for two
types of surveys: Remote or in person.
Remote surveys will collect data about
how participants interact with CDC’s
Web site, social media, mobile-based or
other electronic communication
channels hosting CDC content. Users
will take the survey at their home or
work computers. In person surveys will
have participants take the survey in a
central location where their data can be
captured electronically, as with the
remote survey, but also the participants
can be directly observed. The direct
observation of in person surveys allows
for enhanced collection of information
E:\FR\FM\17DEN1.SGM
17DEN1
]]>Agencies
[Federal Register Volume 74, Number 241 (Thursday, December 17, 2009)]
[Notices]
[Pages 66976-66977]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-30014]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-10-0761]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Randomized Controlled Trial of Routine Screening for Intimate
Partner Violence (OMB No. 0920-0761 Exp. 1/31/2011)--Revision--National
Center for Injury Prevention and Control (NCIPC), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Intimate partner violence (IPV) is a prevalent problem with serious
health consequences that include death, physical injury, increased
rates of physical illness, posttraumatic stress, increased
psychological distress, depression, substance abuse, and suicide. Some
studies suggest that abuse perpetrated by intimate partners tends to be
repetitive and escalates in severity over time. This research has been
the basis for promoting early diagnosis and intervention.
Health care providers appear to be well situated to identify IPV.
Women come into contact with health care services routinely for a
number of reasons such as prenatal care, family planning, cancer
screening, and well baby care. Women experiencing IPV make more visits
to emergency departments, primary care facilities, and mental health
agencies than non-abused women. Considering the magnitude and severity
of IPV, and the potential role health care providers could play in
reducing its serious consequences, numerous professional and health
care organizations have recommended routine screening of women for IPV
in primary care settings. However, various systematic reviews of the
literature have not found evidence for the effectiveness of screening
to improve outcomes for women exposed to IPV.
Based on the recommendations of an expert panel convened, CDC is
proposing to conduct a randomized controlled trial to provide this
evidence. The trial will recruit 2675 women in a network of women's
health clinics. Women attending these clinics tend to be African
American and of lower socioeconomic status. For this study, women will
be randomly allocated to one of three arms: (1) Screened for IPV, and
if disclosing IPV, provided information on available IPV services; (2)
not screened and all receiving information on available IPV services;
or (3) a control group that will not be screened nor receive
information on available IPV services. All three arms will be assessed
with a self-report measure for disability, quality of life, and
utilization of health services at baseline utilizing an audio-computer-
assisted structured interview (A-CASI) and at a 12-month follow-up
utilizing a computerized-assisted telephone interview (CATI). The
results from this Randomized Controlled Trial, will guide CDC as well
as other governmental agencies, professional and health care
organizations, and women's advocate groups in formulating its
recommendations and policies regarding routine screening. A pretest
with 196 women in a women's health clinic was conducted to test the
enrollment, randomization, interview, and follow-up procedures; and
provide estimates for outcome measures. Based on the results of the
pretest, CDC has revised the measures, procedures, and sample size
requirements for the Randomized Controlled Trial. There are no costs to
respondents other than their time to participate in the survey.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per response (in Annual burden
respondents respondent hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Women Seeking Health Care Eligibility 70 1 1/60 2
Services. Script for
Pretest.
Baseline 65 1 15/60 17
Questionnaire
Pretest.
Follow-up 59 1 12/60 12
Questionnaire
Pretest.
[[Page 66977]]
Eligibility 668 1 1/60 12
Script for Main
Study.
Baseline 535 1 16/60 143
Questionnaire
Main Study.
Follow-up 356 1 21/60 125
Questionnaire
Main Study
(estimated 30%
lost to follow-
up).
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 311
----------------------------------------------------------------------------------------------------------------
Dated: December 11, 2009.
Marilyn S. Radke,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. E9-30014 Filed 12-16-09; 8:45 am]
BILLING CODE 4163-18-P
